
Japan has a complex and often-overlooked relationship with altered states of consciousness:
This is a heritage post written from Isha Health's perspective — our team's cultural roots are Japanese, and how we think about ketamine-assisted therapy is informed by that lineage.
Isha Health was founded by physicians with Japanese cultural roots, and the way we approach ketamine-assisted therapy is shaped by that heritage — particularly the emphasis on reverence, nature, and communal support rather than the individualistic, productivity-focused framing that has dominated some Western psychedelic conversations.
This post is a small contribution to broadening how we collectively think about altered states of consciousness and healing.
The Ainu, the Indigenous people of Hokkaido and historically of the northern Japanese islands, have a centuries-old tradition of using Amanita muscaria — the iconic red-and-white "fly agaric" mushroom — in spiritual practice.
In Ainu cosmology, mushrooms are kamuy (spirits or sacred beings). The ceremonial use of Amanita muscaria was understood not as recreational consumption but as communion with the spirit world — a way to receive guidance from ancestors and natural deities. Use was tightly bounded by ritual context, time of year, and the presence of elders who held the knowledge of safe preparation.
The pharmacology is distinct from psilocybin mushrooms. Amanita contains muscimol and ibotenic acid — GABAergic compounds, not serotonergic ones — producing dissociative and dreamlike states rather than the visual, ego-dissolving experiences associated with classic psychedelics.
Shugendō is a syncretic spiritual tradition that blends Shinto, Tantric Buddhism, and folk religion. Practitioners (yamabushi, "those who lie down in the mountains") seek spiritual transformation through demanding practices:
The altered states sought through Shugendō practice are framed as a confrontation with one's small self — facing fear, exhaustion, and discomfort to break through to a different relationship with reality. The use of substances was always secondary to and supportive of the ascetic practice, never the central event.
This framing — substance as one tool among many, embedded in a structured practice — is closer to how modern psychedelic-assisted therapy works at its best than the recreational paradigm that dominates pop culture.
Zen takes a different approach entirely. The practice does not use entheogenic substances; instead, it pursues altered states of consciousness through sustained meditation (zazen).
Key Zen concepts that overlap conceptually with psychedelic experience:
Zen teachers generally caution that substance-induced glimpses of these states are not the same as the realizations that come from sustained practice. The argument: a brief view of a destination is not the same as the journey that builds the capacity to live there. Both can be valuable; they are not interchangeable.
Shinrin-yoku ("forest bathing") was formalized in Japan in the 1980s as a public health practice. Studies have documented physiological effects — reduced cortisol, lower blood pressure, improved heart rate variability — from extended slow walks in forest environments.
While not psychedelic, shinrin-yoku reflects a deeply Japanese stance: altered states of consciousness are often available without pharmacology, through deliberate, embodied contact with the natural world. Modern Japanese culture continues to value this approach.
Matsutake mushrooms occupy a particular place in Japanese culture — not as psychedelics (they're not psychoactive) but as ritual food. They are seasonal, expensive, and prized for their distinct fragrance. The act of foraging and consuming matsutake is treated with the same reverence as a ceremony.
This pattern — making the ordinary sacred through attention and ritual — runs through Japanese aesthetics broadly. The tea ceremony, ikebana (flower arrangement), the meticulous preparation of seasonal meals — all reflect a stance that altered states of awareness can come from full attention to ordinary things, not only from extraordinary experiences.
Despite the rich historical relationship with altered states of consciousness:
This places Japan among the more restrictive countries on psychedelic policy, despite Indigenous and traditional precedent.
Western psychedelic-assisted therapy frameworks (MAPS-style MDMA work, Compass psilocybin protocols, mainstream KAP) tend to emphasize:
Japanese-informed approaches to similar work often emphasize:
Neither framework is inherently better — but the Western default isn't the only legitimate approach. As psychedelic-assisted therapy matures globally, drawing on a wider range of cultural lineages will likely produce better, more flexible models.
Yes, in specific contexts. Ainu shamanism used Amanita muscaria; Shugendō mountain asceticism incorporated entheogenic plants alongside fasting and meditation. Most of mainstream Japanese spiritual tradition (Shinto, Zen, mainline Buddhism) pursued altered states without substances.
Psilocybin, LSD, MDMA, and DMT are all illegal with severe penalties. Ketamine is legal medically but tightly controlled. Japan has among the strictest psychedelic drug policies in the developed world.
"Forest bathing" — a Japanese public health practice involving slow, deliberate walks in forest environments. Studies have documented measurable effects on stress hormones and cardiovascular markers. It's a non-pharmacological altered-state practice that draws on the broader Japanese tradition of seeking transformation through nature.
Zen teachers generally distinguish between substance-induced glimpses and realizations earned through sustained practice. Substances aren't inherently rejected, but the integration into long-term practice matters more than the moment of altered state itself.
Our approach is shaped by the cultural roots of our team — emphasizing reverence, integration with daily life, and the importance of preparation and aftercare. We're a U.S. medical practice operating under U.S. clinical standards, but how we frame the work draws on these traditions. Learn more about our treatment approach.
Considering ketamine therapy? Isha Health offers physician-led at-home treatment with an 88.8% improvement rate. Check appointment availability.
88.8% of Isha Health patients with moderate-to-severe depression show measurable improvement
Based on 546 patients and 1,900+ validated assessments. See our clinical outcomes →
Stay informed on ketamine therapy
Research updates, clinical insights, and mental health resources — delivered to your inbox.